Publikace
- 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer's Disease Treatment2015 | Publikace bez příslušnosti k fakultě
- 2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE12023 | Farmaceutická fakulta v Hradci Králové
- Recent advances in dopamine D-2 receptor ligands in the treatment of neuropsychiatric disorders2023 | Publikace bez příslušnosti k fakultě
- Novel D-2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment2022 | Ústřední knihovna
- UHPLC-HRMS study of pharmacokinetics of a novel hybrid cholinesterase inhibitor K1234: A comparison between in silico, in vitro and in vivo data2022 | Lékařská fakulta v Hradci Králové
- Non-covalent acetylcholinesterase inhibitors: In vitro screening and molecular modeling for novel selective insecticides2022 | Publikace bez příslušnosti k fakultě
- Huprine Y-Tryptophan heterodimers with potential implication to Alzheimer's disease treatment2021 | Farmaceutická fakulta v Hradci Králové, 1. lékařská fakulta
- 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease2021 | Publikace bez příslušnosti k fakultě
- Review of Synthetic Approaches to Dizocilpine2021 | Publikace bez příslušnosti k fakultě
- Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease2021 | Publikace bez příslušnosti k fakultě
Loading network view...